Evaluating Non-Statin Lipid-Lowering Therapies in ASCVD

Turning the focus to non-statin therapies, the panel outlines logistical barriers and discusses the characteristics that guide treatment selection in patients with ASCVD.

EP: 1.How Often Do Patients with ASCVD Achieve Target LDL-C?

EP: 2.Gaps Between Guidelines and Clinical Practice Patterns in ASCVD

EP: 3.Comparing the ACC/AHA and ESC/EAS Cholesterol Management Guidelines

EP: 4.Key Barriers in Implementing Guideline-Directed Cholesterol Treatment

Now Viewing

EP: 5.Evaluating Non-Statin Lipid-Lowering Therapies in ASCVD

EP: 6.Clinical Efficacy of Non-Statin Treatment Options in ASCVD

EP: 7.Non-Statin Therapies: Cost Effectiveness and Clinical Evidence Gaps

EP: 8.Persistence and Discontinuation Rates for Non-Statin Therapies in ASCVD

EP: 9.The Role of Pharmacists in Treating Very High-Risk ASCVD

EP: 10.Valuable Metrics and Improving Adherence in Patients With ASCVD

EP: 11.Successful Collaborative Care Strategies for Pharmacists

Related Videos

Related Content

Advertisement

April 29th 2025

FDA Approves Upadacitinib for Adult Patients With Giant Cell Arteritis

Gillian McGovern, Associate Editor

April 29th 2025

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Alexandra Gerlach, Associate Editor

April 23rd 2025

Study: Mineral and Vitamin Levels in Pregnancy Linked to Midlife Blood Pressure

Kennedy Ferruggia, Assistant Editor

April 22nd 2025

The RIVAWAR Trial and ACS Guidelines for LV Thrombus

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Aislinn Antrim, Managing Editor

April 21st 2025

Migraine With Aura Plays Most Prominent Role in Women With Young-Onset CIS

Gillian McGovern, Associate Editor

April 14th 2025

Study Finds Adverse Pregnancy Outcomes Mediate Association With CVD Risk, Prepregnancy Obesity in Midlife

Gillian McGovern, Associate Editor

Related Content

Advertisement

April 29th 2025

FDA Approves Upadacitinib for Adult Patients With Giant Cell Arteritis

Gillian McGovern, Associate Editor

April 29th 2025

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Alexandra Gerlach, Associate Editor

April 23rd 2025

Study: Mineral and Vitamin Levels in Pregnancy Linked to Midlife Blood Pressure

Kennedy Ferruggia, Assistant Editor

April 22nd 2025

The RIVAWAR Trial and ACS Guidelines for LV Thrombus

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Aislinn Antrim, Managing Editor

April 21st 2025

Migraine With Aura Plays Most Prominent Role in Women With Young-Onset CIS

Gillian McGovern, Associate Editor

April 14th 2025

Study Finds Adverse Pregnancy Outcomes Mediate Association With CVD Risk, Prepregnancy Obesity in Midlife

Gillian McGovern, Associate Editor